-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
Malta Emerges as Premier Low-Season Destination for UK Travelers
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
UK Home Asking Prices Drop £6,745 in November Amid High Mortgage Rates
-
Mbeki Claims No Progress Since 2018; Author Cites Infrastructure and Economic Gains
-
Alex Georgiev Sets Personal Record to Win NCAA Pole Vault at Penn Relays
-
Qatar's Amir and Venezuelan Acting President Discuss Energy Cooperation
-
Emerging Growth Research Highlights Criticality of First Phosphate G7-Backed LFP Battery Onshoring Solution as Cleantech Sector Accelerates Post U.S. Midterms
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Spartan Capital Adds Institutional Investor, Upsizes Credit Facility to $100 Million
-
Diné Development Corporation Named 2026 Minority-Owned Business of the Year by Dayton Business Journal
-
Orlando Dreamers Announce Hundreds of Millions of Additional Financing Under Initial Letter of Intent
-
How to Remotely Access a PLC? Improve Maintenance Efficiency with InHand 4G/5G Industrial Routers
-
Graid Technology Extends VROC(TM) to AMD EPYC(TM) Platforms, Expanding Choice in Enterprise RAID
-
SMX Targets the Missing Link in Global Gold Markets: Proof
-
Lifeloc Reports Third Quarter 2026 Results
Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization
Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent Sensing
Achieves Strategic Inflection Point in 1H 2025 with Partnerships and Operational Breakthroughs
SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 30, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the completion of a 1-for-5 stock consolidation, effective at the opening of trading on June 30, 2025. The move strengthens the Company's capital structure, aligns with Nasdaq listing requirements, and positions Ainos to scale global commercial operations across its AI Nose platforms.
"Ainos is defining the future of olfactory intelligence," said Eddy Tsai, Chairman, President and CEO of Ainos. "The global electronic nose market is expected to grow from $29.8 billion in 2025 to $76.5 billion by 2032, and we're not just participating, we're elevating it. With our strong partners like ASE, Kenmec and ugo, we're enabling AI-powered digital olfaction into mission-critical environments like semiconductor, electronics, and smart factories. I believe these partnerships are the foundation for scalable, recurring revenue through hardware deployments and sensing data services, serving as a reference for other advanced manufacturing clients worldwide."
Second-Half 2025: Commercial Execution and Business Expansion
Following a pivotal first half, Ainos is focused on executing across strategic pillars:
Semiconductor Manufacturing with ASE - Pursue a multi-stage AI Nose rollout roadmap with ASE Technology Holding, beginning with approximately 1,400 units of AI Nose for field pilot, laying foundation to scale deployment to approximately 5,000 units Phase 1 and up 15,000 units in Phase 2, enabling next-generation VOC detection.
Smart Factories in Asia with Kenmec - Plan scaling AI Nose and SLM into Kenmec Mechanical Engineering's smart factory ecosystem, accelerating deployment of multimodal sensory intelligence across robotics, logistics and autonomous manufacturing.
Robotics with ugo - Advance AI Nose field pilots in Japan with ugo for the world's first service robot equipped with a sense of smell; begin field test across Japanese infrastructure sites, targeting utility, maintenance and airport scenarios.
Senior care - Initiate large-scale AI Nose pilot deployment with partners in Japan; evaluate Taiwan opportunities.
VELDONA® Clinical Pipeline - Initiate human clinical trials in Taiwan for HIV-related oral warts and Sjögren's syndrome following recent regulatory approval; continue veterinary trials for FCGS.
Smell Language Model (SLM) - Expand the proprietary scent dataset powering the smell language model (SLM), Ainos' AI architecture that transforms scent into machine-readable Smell ID. The platform has achieved over 90% accuracy in classifying meat, food, and beverage samples, and is now being commercialized across industrial and healthcare settings.
"Smell language model (SLM) will be how we give machines the ability to understand the environment through scent and it's core to the next wave of sensory AI, a key extension from vision and hearing" Eddy commented. "We see tremendous potential in cleanroom, ESG, smart healthcare, smart factory and automation."
Capital Structure Aligned for Growth
The 1-for-5 stock consolidation reduces Ainos' outstanding shares while proportionally increasing share price. Shareholder ownership percentages remain unchanged. The action enhances the Company's readiness for institutional participation and supports its transition into recurring-revenue operations.
First-Half 2025: Strategic Inflection Point Achieved
Ainos' strong first-half performance sets the stage for accelerated second-half execution:
Semiconductor Partnership - Initiated partnership with ASE to explore AI Nose deployment across its key manufacturing networks with 56 smart factories.
Robotic Integration - Completed software-hardware integration of AI Nose into ugo's robots, initiating field pilots in Japan.
Smart Factory Collaboration - Partnered with Kenmec for manufacturing and deployment of AI Nose in smart factory systems across Asia.
Senior Care Validation - Achieved 85%+ accuracy in scent-based hygiene detection across over 2,000 samples in Japan's elderly care sector; further scaling expected in Japan and Taiwan.
Smell ID Expansion - Continued development of proprietary scent database and SLM training models for multi-industry application.
Q1 Revenue Surge - Reported 412% YoY revenue growth, driven by initial AI Nose deployments in senior care pilots.
"Our strategy is clear: building a new sensory layer with AI Nose. We're turning smelltech into an emerging AI infrastructure," Eddy added. "Looking ahead, we'll continue to build strategic relationships across industries and geographies to accelerate adoption of our AI Nose platform and smell language model (SLM). This is just the beginning. Ainos is focused, positioned for scale, and committed to leading the AI-powered SmellTech economy."
About Ainos, Inc.
Ainos, Inc. (NASDAQ: AIMD) is a dual-platform AI and biotech company pioneering SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X (@AinosInc) and LinkedIn for updates.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information
Feifei Shen
[email protected]
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
A.Williams--AT